These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8853959)

  • 21. Targeting colloidal particulates to thoracic lymph nodes.
    Liu J; Wong HL; Moselhy J; Bowen B; Wu XY; Johnston MR
    Lung Cancer; 2006 Mar; 51(3):377-86. PubMed ID: 16413084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
    Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog.
    Kiyokawa H; Igawa Y; Muraishi O; Katsuyama Y; Iizuka K; Nishizawa O
    J Urol; 1999 Feb; 161(2):665-7. PubMed ID: 9915479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
    Ophthalmic Res; 2008; 40(3-4):145-50. PubMed ID: 18421229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
    Reddy ST; Rehor A; Schmoekel HG; Hubbell JA; Swartz MA
    J Control Release; 2006 May; 112(1):26-34. PubMed ID: 16529839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective delivery of pepleomycin to esophageal lymph nodes by activated carbon particles.
    Hirao E; Saito T; Kobayashi M
    Anticancer Res; 1993; 13(4):991-4. PubMed ID: 7688941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of polyanhydrides as localized drug carriers.
    Jain JP; Modi S; Domb AJ; Kumar N
    J Control Release; 2005 Apr; 103(3):541-63. PubMed ID: 15820403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
    Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
    Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387.
    Sklan EH; Gazit A; Priel E
    Virology; 2000 Dec; 278(1):95-102. PubMed ID: 11112485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of prednisolone on the nucleic acid content and RNA synthesis in human lymph nodes in systemic diseases].
    Reztsova VV; Chekharina EA
    Vopr Onkol; 1978; 24(1):21-4. PubMed ID: 345620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential applications of chitosan in veterinary medicine.
    Senel S; McClure SJ
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1467-80. PubMed ID: 15191793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New oral delivery systems for treatment of inflammatory bowel disease.
    Friend DR
    Adv Drug Deliv Rev; 2005 Jan; 57(2):247-65. PubMed ID: 15555741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicines for overcoming biological barriers.
    Alonso MJ
    Biomed Pharmacother; 2004 Apr; 58(3):168-72. PubMed ID: 15082339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regeneration of autotransplanted avascular lymph nodes in the rat is improved by platelet-rich plasma.
    Hadamitzky C; Blum KS; Pabst R
    J Vasc Res; 2009; 46(5):389-96. PubMed ID: 19155630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device.
    Scholz OA; Wolff A; Schumacher A; Giannola LI; Campisi G; Ciach T; Velten T
    Drug Discov Today; 2008 Mar; 13(5-6):247-53. PubMed ID: 18342801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Targeting delivery of liposomal adriamycin by intra-lymphatic infusion].
    Feng B; Lang J; Li D
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):156-8. PubMed ID: 9596890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery to the lymphatic system.
    Porter CJ
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):333-93. PubMed ID: 9450175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
    Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A
    J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.